BRI vs BMI for longevity: Why your waist may matter more than your weight

BRI likely predicts longevity risk better than BMI for many men because it reflects abdominal fat distribution, not just weight for height. If your BMI is “fine” but your waistline is climbing, BRI can be the reality check that pushes you toward the right labs and the right plan.

Key takeaways

• BRI uses height and waist circumference to estimate body roundness on a 1 to 16 scale, with higher scores suggesting more central fat accumulation.
• According to observational research, BRI shows a U shaped relationship with all cause mortality, meaning very low and very high BRI are both linked with higher risk, while the lowest risk sits in the middle range.^[1]
• Two men with the same BMI can carry very different amounts of body fat and visceral fat, which can mask cardiometabolic risk.^[2][3]
• BRI has been reported as a good predictor of metabolic syndrome, a cluster of high risk findings that includes abdominal obesity, high blood pressure, and abnormal glucose and lipids.^[4]
• If high abdominal fat overlaps with low libido, low energy, or poor recovery, a hormone evaluation is reasonable. The AUA guideline bases a diagnosis of testosterone deficiency on symptoms or signs plus total testosterone below 300 ng/dL on two early morning measurements, with LH measured in men with low testosterone.^[5] LH and FSH together show whether the problem starts in the testes or in the brain.

The relationship between BRI, BMI, and longevity in men

BRI may be more useful than BMI, or body mass index, for longevity because it is designed to reflect abdominal fat distribution, which is closely tied to cardiometabolic risk. BMI is weight relative to height. It is simple, but it cannot tell where fat is stored or how much of the body is muscle.

Longevity means how long you live and how many of those years are free of chronic disease. For many men, the main longevity threats are cardiometabolic, a clinical group that includes type 2 diabetes, hypertension, and heart disease. These conditions track closely with central fat gain, especially fat stored deep in the abdomen.

The 2013 paper in the journal Obesity that introduced the body roundness index proposed it as a way to estimate total body fat and visceral fat from body shape.^[6] Visceral fat is fat stored around the organs. It is not the same as the pinchable fat under the skin, and it is the type most consistently linked to chronic disease risk.

How BRI and BMI work

What BMI measures and what it misses

BMI is a ratio of weight to height. It is useful for population level screening, but it collapses body composition into one number. Body composition is what the body is made of, mainly fat mass and lean mass such as muscle.

A key problem for men is that BMI can look “healthy” even when waist size is rising, or it can look “high” in a muscular man with little fat. A 2016 BMJ dose response meta analysis of 230 cohort studies with more than 30 million participants found a J shaped relationship between BMI and all cause mortality in never smokers, with the lowest risk at a BMI of 23 to 24 and an 18% higher risk for each 5 unit increase in BMI.^[7]

What BRI measures: roundness and fat distribution

BRI stands for body roundness index. It is an anthropometric measure, meaning it uses body measurements taken from the outside. BRI uses height and waist circumference to estimate how “round” the body is, on a scale from 1 to 16. Higher scores reflect a rounder shape and suggest more central fat accumulation.

The development paper modeled the body as an ellipse and compared BRI estimates with body fat and visceral fat measured directly in adults.^[6]

Why visceral fat is the longevity problem

Excess visceral fat appears to trigger a cascade of metabolic disturbances that coexist with fat stored in the liver, muscle, and heart, which is why reducing it may play a central role in treating metabolic syndrome.^[8] Metabolic syndrome is a cluster of findings that travel together, including abdominal obesity, elevated blood pressure, abnormal blood sugar regulation, and abnormal lipids.

BRI gets attention because it is built to reflect central fat distribution, and general body fat and central fat do not carry the same risk signal. Two men can share the same BMI, but the one with more abdominal fat is typically the one clinicians worry about most.

The U shaped curve: why very low and very high BRI can both be risky

A 2024 JAMA Network Open cohort study of nearly 33,000 US adults reported a U shaped relationship between BRI and all cause mortality.^[1] All cause mortality means death from any cause, a common way longevity studies measure overall risk. In a U shaped curve, risk is higher at the extremes and lowest in the middle range.

This matters clinically because it discourages “lower is always better” thinking. Very low roundness could reflect undernutrition or loss of lean tissue in some men, while very high roundness likely reflects harmful central adiposity. BMI shows a related pattern: the BMJ meta analysis found a J shaped curve in never smokers and a more U shaped curve in analyses with greater potential for bias, and it attributed part of the extra risk at low BMI to undiagnosed disease.^[7]

If you are working on longevity and also have symptoms that suggest testosterone deficiency, get tested rather than guessing. According to the AUA guideline, diagnosis rests on symptoms or signs plus total testosterone below 300 ng/dL, confirmed on two early morning testosterone draws taken on separate occasions.^[5]

Conditions linked to a high BRI

A high BRI is not a diagnosis. It is a risk signal. Still, the reason BRI is being studied is that higher abdominal roundness tends to cluster with the same conditions that shorten healthy lifespan.

A 2020 meta analysis in Obesity Reviews found that BRI had good ability to identify metabolic syndrome in adults.^[4] BRI has also been studied as a marker of hypertension, insulin resistance, and diabetes, where it generally performs similarly to other waist based measures rather than clearly better. Insulin resistance means cells respond poorly to insulin, so the body needs more insulin to keep blood sugar controlled. Hypertension means persistently elevated blood pressure.

Ethnic background matters too, because fat distribution varies by ethnicity, age, and other factors. A 2002 study in Obesity Reviews found that Singaporean Chinese, Malay, and Indian adults had a BMI about 3 points lower than Caucasians at the same body fat percentage, and that cardiovascular risk factors were already common at a BMI of 22 to 24 and, in men, a waist of 80 to 85 cm.^[2] A 2007 study using DXA and CT scans found that South Asian adults had more body fat than Europeans at the same BMI, and that both Chinese and South Asian adults carried more visceral fat at the same waist circumference.^[3] These are the situations where a waist informed measure can add information, although neither study tested BRI itself.

Both BMI and BRI are indirect measures. They estimate what is happening inside the body based on outside measurements. They do not replace a clinical evaluation, blood pressure, or labs such as HbA1c and lipids, and they cannot directly measure visceral fat the way imaging can.

Symptoms and signals to watch for

Cardiometabolic risk can be silent. Many men feel “mostly fine” until blood pressure, glucose, or lipids have been off for years. Use BRI and BMI as prompts to look for objective signals.

If several of the signals below apply to you, treat it as a prompt to measure and confirm, not a reason to panic. Recheck waist and weight monthly (or at least quarterly) and discuss how often to repeat blood pressure and labs based on your baseline risk and results; many clinicians recheck key cardiometabolic labs within about 3 to 12 months after lifestyle changes or medication adjustments. Seek medical care sooner for very high blood pressure readings, chest pain, shortness of breath, fainting, or rapidly worsening exercise tolerance.

• Your waistline is steadily increasing even if your scale weight is stable. This is the pattern BRI is meant to capture.
• Your pants and belt size are going up over 6 to 12 months.
• Blood pressure readings are trending high at home, at the pharmacy kiosk, or at annual visits. Hypertension is often symptom free.
• HbA1c is rising. HbA1c is a 2 to 3 month average of blood sugar.
• Triglycerides are high or HDL is low. Lipids are fats in the blood measured on a standard cholesterol panel.
• You have a family history of type 2 diabetes, early heart disease, or hypertension, which can increase the stakes of central fat gain.
• Performance changes you cannot explain such as lower work capacity, slower recovery, and persistent low energy. These are nonspecific, but they are reasons to check labs rather than self diagnose.

What to do about it

The practical sequence is to measure shape and weight, confirm risk with labs, and then act on what you find with a plan you can stick to.

1. Step 1: measure BRI and BMI the same way every time. Calculate BMI from height and weight, then measure waist and use a reputable BRI calculator. Measure waist at the same landmark each time, keep the tape snug but not tight, and measure under similar conditions, such as in the morning before a big meal. Consistency matters more than perfection. If you also want a hip based metric, that is a separate measure such as waist to hip ratio, not BRI.
2. Step 2: pair the number with real health data. Anthropometrics are most useful when combined with biomarkers like HbA1c and lipid levels, along with an assessment of physical activity and diet. If your BRI is trending high, ask your clinician for a cardiometabolic workup. If symptoms suggest testosterone deficiency, the AUA guideline recommends measuring LH in men with confirmed low testosterone,^[5] and FSH is checked alongside it. The gonadotropin pattern shows whether hypogonadism is primary or secondary and guides treatment. In secondary hypogonadism the testes are intact, so fertility preserving alternatives to testosterone therapy, such as enclomiphene, which raises the body’s own LH and testosterone, may be considered. According to the AUA guideline, testosterone therapy should not be prescribed to men who are currently trying to conceive, because it suppresses sperm production.^[5]
3. Step 3: build a plan aimed at reducing visceral fat and protecting lean mass. The target is not just weight loss. It is waist reduction with maintained strength. A 2013 meta analysis in PLOS ONE of 15 studies with 852 overweight adults found that exercise without calorie restriction reduced visceral fat, with moderate or high intensity aerobic training showing the greatest effect and reductions of more than 40 cm² on CT in men after as little as 12 weeks.^[8] Anchor your week around progressive resistance training, regular aerobic work you can recover from, and nutrition that supports a sustainable calorie deficit if fat loss is needed. Recheck waist, weight, and key labs on a schedule you and your clinician agree on, then adjust.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have, interpreted by licensed providers. When appropriate, those providers may prescribe enclomiphene or an enclomiphene plus tadalafil tablet. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

Myth vs fact

Myth: “BMI is all I need for longevity.”

Fact: BMI misses fat distribution. BRI adds information by reflecting abdominal roundness, which is closely tied to cardiometabolic risk.

Myth: “If my BMI is normal, belly fat cannot be a problem.”

Fact: Men can have a normal BMI and still carry high central fat. That is one reason waist based tools like BRI are being studied.

Myth: “Lower BRI is always better.”

Fact: Mortality risk has been reported to follow a U shaped curve across BRI values, with higher risk at both very low and very high levels.^[1]

Myth: “One number can predict exactly how long I will live.”

Fact: Longevity is multifactorial. BRI and BMI are screening tools that should be interpreted with blood pressure, HbA1c, lipids, fitness, and lifestyle.

Myth: “If I have low energy and belly fat, I should start testosterone on my own.”

Fact: Treatment decisions should follow a diagnosis. According to the AUA guideline, that means symptoms or signs plus low total testosterone confirmed on two early morning tests, with LH measured to help distinguish primary from secondary hypogonadism so treatment can be matched to the cause.^[5] Testosterone therapy suppresses sperm production, so men who want to preserve fertility need a different approach.

Bottom line

BRI adds information that BMI lacks for longevity screening in men because it is driven by waist size and better reflects abdominal fat. Central fat is closely linked to cardiometabolic risk, even when BMI looks “normal.” Use both measures, then confirm risk with blood pressure and labs so you can target the real problem early.

References

1. Zhang X, Ma N, Lin Q, et al. Body Roundness Index and All-Cause Mortality Among US Adults. JAMA Netw Open. 2024;7:e2415051. PMID: 38837158
2. Deurenberg-Yap M, Chew SK, Deurenberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev. 2002;3:209-15. PMID: 12164474
3. Lear SA, Humphries KH, Kohli S, et al. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (Silver Spring). 2007;15:2817-24. PMID: 18070773
4. Rico-Martín S, Calderón-García JF, Sánchez-Rey P, et al. Effectiveness of body roundness index in predicting metabolic syndrome: A systematic review and meta-analysis. Obes Rev. 2020;21:e13023. PMID: 32267621
5. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432. PMID: 29601923
6. Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring). 2013;21:2264-71. PMID: 23519954
7. Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156. PMID: 27146380
8. Vissers D, Hens W, Taeymans J, et al. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One. 2013;8:e56415. PMID: 23409182